Inside the Lemonaid Health Buy: Kyle Pretsch on Bambu Ventures’s Bold Play
Bambu Ventures's Kyle Pretsch dives into Lemonaid’s $10M buyout, down from 23andMe’s $400M price tag, and what’s next after Chrome Co.’s dramatic pivot.
From dire wolves to new species targets, scientists at Colossal Biosciences are using gene editing to revive extinction and reshape biodiversity as we know it.
R.J. Hottovy, Head of Analytical Research at Placer.ai, breaks down restaurant trends, pricing power, and which chains are winning this earnings season.
William Shatner and LifeWave CEO David Schmidt share lessons from his “world’s oldest intern” experience and offer advice for young professionals starting out.
The Live Nation ruling is in. Diana Moss of the Progressive Policy Institute joins us to unpack what it means for competition, consumers, and live music.